Products
14846 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Newmont Constant Leverage with ISIN code: CH1450968743 | Newmont | Constant Leverage | Short | ― | 114.664 | 0.019 | 0.002 | 0.021 | 1 | -9.52% | -9.52% | -26.92% | 21 Aug. 2025 | |
| Newmont Constant Leverage with ISIN code: CH1450970046 | Newmont | Constant Leverage | Short | ― | 114.664 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 3 Nov. 2025 | |
| Nike Constant Leverage with ISIN code: CH1119067994 | Nike | Constant Leverage | Short | ― | 42.698 | 1.75 | 0.020 | 1.77 | 1 | -1.13% | 18.24% | 150.00% | 12 May. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1450969097 | Nokia | Constant Leverage | Short | ― | 7.591 | 0.004 | ― | ― | 1 | 0.00% | -33.33% | -66.67% | 21 Aug. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 7.591 | 0.023 | 0.002 | 0.025 | 1 | -8.00% | -20.69% | -36.11% | 30 Nov. 2022 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 120.489 | 0.12 | 0.030 | 0.15 | 1 | -20.00% | 9.09% | -25.00% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 120.489 | 0.024 | 0.005 | 0.029 | 1 | -17.24% | 14.29% | -29.41% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 120.489 | 0.072 | 0.005 | 0.077 | 1 | -6.49% | 9.09% | -20.88% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 120.489 | 0.021 | 0.005 | 0.026 | 1 | -19.23% | -12.50% | -22.22% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 120.489 | 0.69 | 0.050 | 0.74 | 1 | -6.76% | 0.00% | -10.39% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 237.436 | 6.4 | 0.120 | 6.52 | 1 | -1.84% | -5.19% | 0.00% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 237.436 | 0.23 | 0.050 | 0.28 | 1 | -17.86% | -20.69% | -14.81% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 237.436 | 0.014 | 0.005 | 0.019 | 1 | -26.32% | -30.00% | -26.32% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1290993240 | Nvidia | Constant Leverage | Short | ― | 178.215 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -88.89% | 11 Mar. 2024 | |
| Nvidia Constant Leverage with ISIN code: CH1450967356 | Nvidia | Constant Leverage | Short | ― | 178.215 | 0.016 | 0.002 | 0.018 | 1 | -11.11% | -15.79% | -46.67% | 9 Jul. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1450968420 | Nvidia | Constant Leverage | Short | ― | 178.215 | 0.38 | 0.020 | 0.4 | 1 | -5.00% | -13.64% | -32.14% | 21 Aug. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1362351657 | Nvidia | Constant Leverage | Short | ― | 178.215 | 0.15 | 0.020 | 0.17 | 1 | -11.76% | -11.76% | -11.76% | 27 Nov. 2024 | |
| Nvidia Constant Leverage with ISIN code: CH1423415657 | Nvidia | Constant Leverage | Short | ― | 178.215 | 0.062 | 0.002 | 0.064 | 1 | -3.13% | -8.82% | -18.42% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1450969840 | Nvidia | Constant Leverage | Short | ― | 178.215 | 5.36 | 0.060 | 5.42 | 1 | -1.11% | -8.53% | -17.67% | 3 Nov. 2025 | |
| Orange Constant Leverage with ISIN code: CH1119067416 | Orange | Constant Leverage | Short | ― | 18.133 | 0.21 | 0.040 | 0.25 | 1 | -16.00% | -25.00% | -22.22% | 9 May. 2022 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.